the importance of timing in autologous transplantation for multiple myeloma
Published 1 year ago • 996 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
2:10
phase ii study of epd maintenance after second autologous transplant for multiple myeloma
-
2:22
the benefit of autologous transplantation in the era of novel agents in multiple myeloma
-
3:06
the importance of autologous transplantation in the era of immunotherapy
-
2:28
is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
-
0:45
auto-allo tandem sct for myeloma
-
3:18
automated hospital blood analyser: part 1 introduction
-
2:48
bortezomib maintenance with dex post-transplant for high-risk myeloma
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
1:53
the future of multiple myeloma treatment
-
3:33
determining the optimal sequencing of bispecifics and car-t cells in patients with myeloma
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
0:43
why should autologous transplant remain the soc in myeloma?
-
2:55
covid-19 & multiple myeloma: patient management
-
1:44
optimal treatment sequencing in multiple myeloma
-
4:36
update on auto-sct for myeloma
-
5:06
advances in immunotherapy for multiple myeloma and future outlooks
-
1:59
the role of upfront double auto-sct in high-risk myeloma
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
2:44
myeloma qol through induction and maintenance
-
1:01
car-t: myeloma toxicities